Literature DB >> 4110342

Correlation between serum alpha-globulin and plasma inhibitory effect on PHA-stimulated lymphocytes in colon cancer patients.

C C Hsu, P LoGerfo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4110342     DOI: 10.3181/00379727-139-36189

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  8 in total

1.  Reversal of defective lymphoproliferation in postoperative patients with colon cancer.

Authors:  L Schindler; M Leroux; G F Zimmermann; M Betzler; H Kirchner
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Editorial: Plasma proteins in cancer surveillance.

Authors: 
Journal:  Br Med J       Date:  1975-05-24

3.  Normal immunosuppressive protein: inhibitory effect on immune response against tumour cells.

Authors:  N Hanna; H Ovadia; D Nelken
Journal:  Immunology       Date:  1978-06       Impact factor: 7.397

4.  Serum immunomodulatory factors in gastrointestinal diseases. A 30-50-kD serum fraction in Crohn's disease capable of modulating lymphocyte activation.

Authors:  L Biancone; M Boirivant; S Fais; G L Ricci; R Paganelli; F Pallone
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

5.  [Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-05-01

6.  Immunosuppressive acidic protein (IAP) in gastric cancer patients.

Authors:  N Shimizu; T Yamane; T Karino; R Hamazoe; Y Osaki; H Kanayama; M Maeta; S Koga
Journal:  Jpn J Surg       Date:  1983-07

7.  Sialoproteinaemia: lack of correlation with inhibition of in vitro lymphoblastosis induced by phytohaemagglutinin or alloantigen.

Authors:  B N Gray; R R Kopito; L L Anderson; O L Baralt; C K Connery; E Watkins
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

8.  Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Authors:  W H Brooks; M G Netsky; D E Normansell; D A Horwitz
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.